ASCENTAGE PHARMA GR-ADR (AAPG:NASDAQ)
$14.75 0.2 (1.3746%)
Analysed ASCENTAGE PHARMA GR-ADR (AAPG:NASDAQ) News Sources
Ascentage Pharma Appoints Dr. Faiçal Miyara as Chief Business Officer and Jim Ziegler as Chief Commercial Officer
02-08-2026
yahoo.com
Ascentage Pharma to Report 2026 Six Month Interim Results and Provide Corporate Update on August 19, 2026
05-08-2026
yahoo.com
CORRECTION: Ascentage Pharma to Report 2026 Six Month Interim Results and Provide Corporate Update on August 19, 2026
05-08-2026
yahoo.com
Ascentage Pharma to Participate in the Evercore 2nd Annual China Biotech Summit
13-08-2026
yahoo.com
Ascentage Pharma Group International (SEHK:6855) Could Be 18% Undervalued After Half Year Losses
28-08-2026
yahoo.com
Ascentage Pharma Reports 2026 Interim Unaudited Financial Results and Provides Business Updates
19-08-2026
yahoo.com
Ascentage Pharma Group International H1 Earnings Call Highlights
20-08-2026
marketbeat.com
ASCENTAGE PHARMA GROUP INTERNATIONAL Q2 2026 Earnings Call Summary
21-08-2026
moby.co
Ascentage Pharma to Participate in Four Upcoming Investor Conferences
02-09-2026
yahoo.com
3 Small-Cap Stocks With Catalysts That Could Put Them in the Spotlight
05-10-2026
marketbeat.com
What is the current price of ASCENTAGE PHARMA GR-ADR (AAPG:NASDAQ)?
The current price of ASCENTAGE PHARMA GR-ADR (AAPG:NASDAQ) is $14.75.
ASCENTAGE PHARMA GR-ADR (AAPG:NASDAQ) absolute price change since previous trading day?
The absolute price change of ASCENTAGE PHARMA GR-ADR (AAPG:NASDAQ) since the previous trading day is $0.2.
ASCENTAGE PHARMA GR-ADR (AAPG:NASDAQ) percentage price change since previous trading day?
The percentage price change of ASCENTAGE PHARMA GR-ADR (AAPG:NASDAQ) since the previous trading day is 1.3746%.
What is the most recent average sentiment score for ASCENTAGE PHARMA GR-ADR (AAPG:NASDAQ)?
The most recent average sentiment score for ASCENTAGE PHARMA GR-ADR (AAPG:NASDAQ) is 63 out of 100.
What is the most recent average sentiment for ASCENTAGE PHARMA GR-ADR (AAPG:NASDAQ)?
The most recent sentiment for ASCENTAGE PHARMA GR-ADR (AAPG:NASDAQ) is .
SEC-8K** Filing Available For ASCENTAGE PHARMA GR-ADR (AAPG:NASDAQ)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.